Novo Holdings A/S - Oct 13, 2025 SCHEDULE 13G Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (FDMT)

Filing Manager: Novo Holdings A/S
Reporting Manager: Novo Holdings A/S
Security: 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: FDMT
Shares outstanding: 46.7M shares
Disclosed Ownership: 3.18M shares
Ownership: 6.8%
Form type: SCHEDULE 13G
Date filed: 10/20/2025, 05:12 PM
Date of event: Oct 13, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Novo Holdings A/S	6.8%	3.18M	3.18M	0	Barbara Fiorini	Barbara Fiorini, General Counsel, Finance & Operations